Article

Pharmacotherapy for Posttraumatic Stress Disorder and Other Trauma-Related Disorders

Mary F. Dent and J. Douglas Bremner

in Oxford Handbook of Anxiety and Related Disorders

Published in print September 2008 | ISBN: 9780195307030
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780195307030.013.0030

Series: Oxford Library of Psychology

 Pharmacotherapy for Posttraumatic Stress Disorder and Other Trauma-Related Disorders

More Like This

Show all results sharing these subjects:

  • Psychology
  • Clinical Psychology

GO

Show Summary Details

Preview

Posttraumatic stress disorder (PTSD) can cause serious chronic psychological impairments in a significant number of persons who have been exposed to an extreme traumatic event. Finding effective, well-tolerated pharmacological treatments for this disorder is an ongoing research effort. This chapter reviews recent thinking that PTSD results from dysfunctions in the neural systems mediating fear learning and memory. These systems are modulated by dopamine, GABA, norepinephrine, and serotonin. Drugs that have been investigated to alleviate PTSD symptoms affect these neuromodulators and include all classes of antidepressants, mood stabilizers, and antipsychotics. To date, the SSRI antidepressants, particularly paroxetine, have shown the best evidence for alleviating most PTSD symptoms in most people. Drugs that promote extinction of fear learning are currently being investigated.

Keywords: acute stress; anticonvulsants; antidepressants; antipsychotics; mood stabilizers; neurobiology; pharmacotherapy; posttraumatic stress disorder

Article.  9340 words. 

Subjects: Psychology ; Clinical Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.